tricalcium phosphate has been researched along with Infections, Orthomyxoviridae in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hurst, BL; Morçӧl, T; Tarbet, EB | 1 |
| Baudner, BC; Del Giudice, G; Hilbert, AK; Kazzaz, J; Manini, I; Montomoli, E; Nuti, S; O'Hagan, DT; Rappuoli, R; Scheffczik, H; Singh, M; Tavarini, S; Ugozzoli, M; Wack, A | 1 |
2 other study(ies) available for tricalcium phosphate and Infections, Orthomyxoviridae
| Article | Year |
|---|---|
Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Viral; Calcium Phosphates; Dose-Response Relationship, Immunologic; Female; Hemagglutination Inhibition Tests; Humans; Immunogenicity, Vaccine; Immunoglobulin G; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Mice; Nanoparticles; Neutralization Tests; Off-Label Use; Orthomyxoviridae Infections; Pandemics; Vaccination; Vaccines, Inactivated | 2017 |
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Antibody Specificity; Calcium Phosphates; Cell Line; Emulsions; Female; Immunoglobulin G; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Injections, Intramuscular; Interferon-gamma; Lactic Acid; Mice; Mice, Inbred BALB C; Neutralization Tests; Orthomyxoviridae; Orthomyxoviridae Infections; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polysorbates; Spleen; Squalene; Th1 Cells; Vaccines, Subunit | 2008 |